SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001047469-15-007440
Filing Date
2015-09-21
Accepted
2015-09-21 16:34:49
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-1/A a2226009zf-1a.htm F-1/A 3347125
2 EX-5.1 a2226009zex-5_1.htm EX-5.1 66374
3 EX-10.14 a2225905zex-10_14.htm EX-10.14 109080
4 EX-23.1 a2225905zex-23_1.htm EX-23.1 4088
5 EX-23.2 a2225905zex-23_2.htm EX-23.2 4230
6 EX-23.3 a2225905zex-23_3.htm EX-23.3 3407
7 G400376.JPG g400376.jpg GRAPHIC 20191
8 G456181.JPG g456181.jpg GRAPHIC 121631
9 G815679.JPG g815679.jpg GRAPHIC 42419
10 G715597.JPG g715597.jpg GRAPHIC 34175
11 G454757.JPG g454757.jpg GRAPHIC 17289
12 G852078.JPG g852078.jpg GRAPHIC 30729
  Complete submission text file 0001047469-15-007440.txt   3903162
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: F-1/A | Act: 33 | File No.: 333-206654 | Film No.: 151117695
SIC: 2834 Pharmaceutical Preparations